Why the study?
The study was designed to obtain contemporary real-world data on antithrombotic regimens and related outcomes after PCI in patients with an indication for oral anticoagulation.
Does dual antithrombotic therapy reduce bleeding without increasing ischemic events compared to triple antithrombotic therapy in patients undergoing PCI with an indication for OAC?
Does dual antithrombotic therapy reduce bleeding without increasing ischemic events compared to triple antithrombotic therapy in patients undergoing PCI with an indication for OAC?
In a real-world registry, dual antithrombotic therapy after PCI in patients requiring OAC reduced clinically relevant bleeding without significantly increasing ischemic events compared to triple therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bor et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: